The Fourth INTERMACS Annual Report: 4,000 implants and counting
The Fourth INTERMACS Annual Report: 4,000 implants and counting
复制标题
DOI：
10.1016/j.healun.2011.12.001
复制
发表时间：
2012-02-01
影响因子：
8.9
通讯作者：
Young, James B.
中科院分区：
文献类型：
--
作者：
Kirklin, James K.;Naftel, David C.;Young, James B.
机械辅助循环支持机构间登记处（INTERMACS）的第四次年度报告总结并分析了前5年的患者和数据收集。数据库中输入了4，000多名患者，记录了泵技术的演变、植入策略和植入前患者概况。提供了整个成人初次植入人群的风险因素分析，并检查了患者特征的近期组成。目前使用连续泵的精算生存率在1年时超过80%，在2年时超过70%。J Heart Lung Transplant 2012;31：117-26（C）2012国际心肺移植学会。All rights reserved.
The Fourth Annual Report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 5 years of patient and data collection. With more than 4,000 patients entered into the database, the evolution of pump technology, strategy at implant, and pre-implant patient profiles are chronicled. A risk factor analysis of the entire adult primary implant population is provided, and the recent composition of patient profiles is examined. Current actuarial survival with continuous-flow pumps exceeds 80% at 1 year and 70% at 2 years. J Heart Lung Transplant 2012;31:117-26 (C) 2012 International Society for Heart and Lung Transplantation. All rights reserved.